Blefaritis
Epidemiologia

Blefaritis jest powszechnym schorzeniem okulistycznym, dotykającym od 37% do 47% pacjentów w krajach wysoko rozwiniętych, z częstością występowania rosnącą wraz z wiekiem, szczególnie u osób powyżej 50 roku życia. Epidemiologia wskazuje na różne podtypy blefaritis, z gronkowcowym zapaleniem powiek częściej występującym u kobiet (80% przypadków, średni wiek 42 lata), a łojotokowym i chorobą gruczołów Meiboma (MGD) z równym rozkładem płci i średnim wiekiem około 50 lat. W populacji ogólnej częstość blefaritis u osób ≥40 lat wynosi 8,8%, a u osób powyżej 60 roku życia może sięgać nawet 67%. Szczególną uwagę zwraca blefaritis wywołany przez roztocza Demodex, których obecność wzrasta z wiekiem, osiągając 100% u osób >70 lat, a współczynnik szans na związek z blefaritis wynosi 4,89. Choroba często współistnieje z zespołem suchego oka (25-50% pacjentów z gronkowcowym zapaleniem powiek), chorobami dermatologicznymi (np. trądzik różowaty, łojotokowe zapalenie skóry) oraz schorzeniami układowymi i psychicznymi, co komplikuje jej obraz kliniczny i epidemiologiczny.

Epidemiologia Blefaritis

Blefaritis jest jednym z najczęściej spotykanych schorzeń w praktyce okulistycznej, stanowiąc istotny problem zdrowotny na całym świecie. Dane epidemiologiczne wskazują, że w Stanach Zjednoczonych i innych krajach wysoko rozwiniętych, schorzenie to dotyka znaczący odsetek populacji dorosłej. Według badań szacuje się, że między 37% a 47% pacjentów leczonych przez specjalistów ochrony wzroku w Stanach Zjednoczonych cierpi na blefaritis, co czyni go jednym z najczęstszych zaburzeń okulistycznych obserwowanych w praktyce klinicznej.12 Niektóre dane sugerują nawet, że problem ten może dotyczyć ponad 180 milionów Amerykanów.34

W skali globalnej, badanie przekrojowe przeprowadzone w Hiszpanii wykazało, że objawowa i bezobjawowa dysfunkcja gruczołów Meiboma (MGD) dotknęła odpowiednio około 21,9% i 8,6% populacji ogólnej.5 Z kolei 10-letnie badanie przeprowadzone w Korei Południowej (2004-2013) określiło ogólną zachorowalność na blefaritis na poziomie 1,1 na 100 osobolat, przy czym zachorowalność rosła z czasem i była wyższa u pacjentek płci żeńskiej.6

Występowanie według wieku

Chociaż blefaritis może dotykać osoby w każdym wieku i z każdego pochodzenia etnicznego, jego częstość występowania wykazuje tendencję wzrostową wraz z wiekiem, prawdopodobnie ze względu na wpływ naturalnego procesu starzenia na funkcję gruczołów Meiboma. Stan ten jest najczęściej obserwowany u osób w wieku 50 lat lub starszych.78 W jednym z badań przeprowadzonych w ośrodku medycznym na grupie 90 pacjentów z przewlekłym blefaritis, średni wiek pacjentów wynosił 50 lat.9

W porównaniu z pacjentami z innymi formami blefaritis, pacjenci z gronkowcowym zapaleniem powiek okazali się stosunkowo młodsi (średnio 42 lata) i w większości były to kobiety (80%).1011 Dla porównania, w przypadku łojotokowego zapalenia powiek średni wiek pacjentów wynosił około 50 lat, a w przypadku choroby gruczołów Meiboma (MGD) również około 50 lat.12

Badania wskazują, że częstość występowania blefaritis u osób w wieku 40 lat lub starszych wynosi 8,8%.13 Niektóre źródła donoszą, że schorzenie to jest obserwowane nawet u 67% osób powyżej 60 roku życia.14 Ogólnie rzecz biorąc, blefaritis najczęściej pojawia się w czwartej i piątej dekadzie życia.15

Różnice związane z płcią

Epidemiologia blefaritis wydaje się być również zależna od płci. Niektóre badania sugerują, że kobiety są bardziej narażone na pewne podtypy blefaritis, w tym gronkowcowe zapalenie powiek. Na przykład badanie przeprowadzone w jednym ośrodku wykazało, że kobiety, ze średnią wieku 42 lata, stanowiły większość pacjentów z gronkowcowym zapaleniem powiek.1617

Dane dotyczące rozkładu płci różnią się w zależności od typu blefaritis:

  • Gronkowcowe zapalenie powiek – częstsze u kobiet1819
  • Łojotokowe zapalenie powiek – równa częstość występowania u mężczyzn i kobiet20
  • Choroba gruczołów Meiboma (MGD) – równie często występuje u mężczyzn i kobiet21

Jednak według niektórych nowszych badań, częstość występowania blefaritis może być ogólnie wyższa u kobiet niż u mężczyzn, szczególnie w przypadku kobiet powyżej 50 roku życia.2223

Różnice etniczne i geograficzne

Nie stwierdzono istotnych różnic rasowych w częstości występowania blefaritis. Schorzenie może dotykać wszystkie grupy etniczne i nie wykazano preferencji rasowych.2425 Jednakże, badania lokalne mogą wskazywać na pewne różnice w rozpowszechnieniu blefaritis w różnych regionach świata, co może być związane z różnicami w diagnostyce, kryteriach rozpoznania, a także czynnikach środowiskowych i stylu życia.

W badaniu przekrojowym przeprowadzonym w Bogocie (Kolumbia) w 2021 roku, częstość występowania blefaritis u dorosłych pacjentów konsultujących się ze specjalistami ochrony wzroku wynosiła aż 68%. Najczęstszym typem było tylne zapalenie powiek (55,8%), następnie zapalenie brzegu powiek (31,6%) i przednie zapalenie powiek (12,6%).26

Nadzór i monitorowanie Blefaritis

Mimo że blefaritis jest częstym schorzeniem, istnieje zaskakująco mało danych epidemiologicznych w literaturze recenzowanej dotyczących jego rzeczywistego rozpowszechnienia w populacji ogólnej.2728 Dodatkowo, brak jest ustandaryzowanych kryteriów diagnostycznych, co utrudnia porównanie danych z różnych regionów i ośrodków.

Monitorowanie blefaritis jest utrudnione przez kilka czynników:

  • Znaczące nakładanie się objawów i oznak z innymi patologiami, takimi jak zespół suchego oka czy alergiczne zapalenie spojówek, prowadzi do zamieszania przy ustalaniu podstawowej diagnozy29
  • Blefaritis jest często niedodiagnozowany i niedoceniany, pomimo jego światowego rozpowszechnienia30
  • Brak rutynowych badań przesiewowych w kierunku roztoczy Demodex i brak standardowych kryteriów diagnostycznych dla blefaritis Demodex31
  • Niska zgłaszalność pacjentów na wizyty kontrolne – w jednym z badań wykazano, że 82,4% pacjentów nie wróciło, aby ocenić wynik leczenia32

Współwystępowanie z innymi schorzeniami

Blefaritis często współwystępuje z innymi chorobami, co może wpływać na jego epidemiologię i nadzór. Do najczęstszych chorób współistniejących należą:

Blefaritis Demodex

Szczególnym podtypem blefaritis, który zyskuje coraz większą uwagę w badaniach epidemiologicznych, jest blefaritis wywołany przez roztocza Demodex. Kilka istotnych obserwacji epidemiologicznych dotyczy tego podtypu:

  • Roztocza Demodex można znaleźć u 20% do 80% wszystkich ludzi, a częstość ich występowania wzrasta z wiekiem42
  • U osób powyżej 70 roku życia rozpowszechnienie roztoczy Demodex osiąga 100%43
  • Badanie przeprowadzone w szpitalu w Polsce na 435 pacjentach zidentyfikowało blefaritis Demodex u 95% osób w wieku 71 lat lub starszych, 87% osób w wieku 51-70 lat i 13% osób w wieku 3-15 lat44
  • Podobne wyniki odnotowano w innym polskim badaniu szpitalnym obejmującym 1499 pacjentów, które zidentyfikowało blefaritis Demodex u 77% osób w wieku 70 lat lub starszych i 8% osób w wieku 25 lat lub młodszych45
  • Blefaritis Demodex jest rzadki u pacjentów pediatrycznych, ale jest częstszy wśród dzieci z określonymi czynnikami ryzyka, szczególnie niedożywionych (25%) lub chorych na nowotwory (32%)46

Meta-analiza potwierdziła związek między zarażeniem Demodex a zapaleniem powiek. Współczynnik szans wynosił 4,89, co wykazuje statystycznie istotny związek między Demodex a blefaritis.47 Inne badanie wykazało, że pacjenci cierpiący na blefaritis mają prawie 2,5-krotnie wyższe ryzyko zakażenia Demodex niż ci bez blefaritis.48

Badania epidemiologiczne i bazy danych

Pomimo znaczenia klinicznego blefaritis, badania epidemiologiczne dotyczące tego schorzenia są stosunkowo ograniczone. Przeszukiwanie baz MEDLINE, PubMed, EBSCO, Cochrane, PROQUEST i Google Scholar w czerwcu 2022 roku ujawniło, że nie było znanych badań mierzących blefaritis Demodex w komercyjnych bazach ubezpieczeniowych, Medicare lub Medicaid.49

Niedobór badań epidemiologicznych nad blefaritis odzwierciedla się w braku rutynowych badań przesiewowych i ustandaryzowanych kryteriów diagnostycznych. Jednocześnie, rosnąca świadomość rozpowszechnienia tej choroby, szczególnie w ostatniej dekadzie, skłoniła środowisko okulistyczne do priorytetowego traktowania badań nad etiologią i skutecznymi metodami terapeutycznymi.50

Dostępne są raporty rynkowe analizujące epidemiologię blefaritis w głównych regionach świata, w tym w Stanach Zjednoczonych, UE5 (Niemcy, Hiszpania, Włochy, Francja i Wielka Brytania), Japonii i Chinach.5152 Według niektórych z tych analiz, Stany Zjednoczone mają największą pulę pacjentów z blefaritis i reprezentują największy rynek dla jej leczenia.53

Stopień zaawansowania choroby

Badania dotyczące ciężkości blefaritis wskazują na następujący rozkład:

Stopień zaawansowania Odsetek pacjentów
Łagodny 55% – 57,8%
Umiarkowany 40% – 42,6%
Ciężki 1,6% – 3,5%

54

Podział płci wśród pacjentów z blefaritis wskazuje, że kobiety stanowią około 60% przypadków, a mężczyźni 40%.5556

Wpływ na zdrowie publiczne

Blefaritis, mimo że rzadko zagraża życiu, ma znaczący wpływ na jakość życia pacjentów i stanowi istotne obciążenie dla systemów opieki zdrowotnej. Związana z nim chorobowość obejmuje utratę funkcji wzrokowych, dobrego samopoczucia i zdolności do wykonywania codziennych czynności życiowych.57

Co istotne, badania wykazały, że pacjenci z blefaritis są narażeni na podwyższone ryzyko lęku i depresji. Współczynnik zapadalności na lęk był 1,67 razy wyższy w kohorcie z blefaritis niż w kohorcie bez blefaritis (15,9 vs 9,5 na 1000 osobolat). Podobnie, zapadalność na depresję była 1,52 razy wyższa w kohorcie z blefaritis (7,66 vs 5,05 na 1000 osobolat).5859

Z perspektywy zdrowia publicznego, blefaritis stanowi znaczące wyzwanie ze względu na:

  • Wysoką częstość występowania w populacji ogólnej60
  • Chroniczny charakter wymagający długotrwałego leczenia i nadzoru61
  • Potencjalne powikłania, w tym uszkodzenia powiek z nieprawidłowym wzrostem rzęs (trichiaza) lub nieprawidłowościami położenia powiek (entropion i ektropion)62
  • Wpływ na jakość życia i funkcjonowanie społeczne pacjentów63
  • Niedodiagnozowanie i niewystarczające leczenie, co wpływa na jakość życia wielu pacjentów64

Warto zauważyć, że ze względu na starzenie się populacji, częstość występowania blefaritis, szczególnie związanego z roztoczami Demodex, prawdopodobnie będzie wzrastać, co czyni świadomość i skuteczne zarządzanie tym schorzeniem niezbędnym elementem opieki zdrowotnej.65

Wyzwania w leczeniu i monitorowaniu

Leczenie blefaritis stanowi wyzwanie z kilku powodów:

  • Brak dobrze kontrolowanych badań klinicznych, które wspierałyby zatwierdzenie przez FDA miejscowych środków leczniczych zarówno na przednie, jak i tylne zapalenie powiek66
  • Środki higieniczne rzadko całkowicie leczą blefaritis67
  • Niska compliance pacjentów – badania wykazały, że tylko połowa osób, które rozpoczynają leczenie mające na celu utrzymanie czystości powiek, kontynuuje je po sześciu tygodniach68
  • Obecne opcje zarządzania blefaritis Demodex obejmują produkty zawierające olejek z drzewa herbacianego, terpinen-4-ol i/lub linalol; jednak stosowanie tych produktów może nie całkowicie eliminować roztocza, może tylko częściowo łagodzić objawy i może powodować podrażnienia69

W celu poprawy monitorowania i leczenia blefaritis, Amerykańska Akademia Okulistyki (AAO) zaleca w swoich wytycznych z 2022 roku organizowanie wizyt kontrolnych w celu uzyskania wywiadu z interwału, pomiaru ostrości wzroku, przeprowadzenia zewnętrznych badań fizykalnych i biomikroskopii w lampie szczelinowej.70

Lepsze zrozumienie charakterystyk epidemiologicznych blefaritis i wrażliwości przeciwdrobnoustrojowej bakterii zaangażowanych w ten proces umożliwi oferowanie skuteczniejszych metod leczenia.7172 Istnieje również potrzeba prowadzenia badań nad częstością występowania przedniego, brzeżnego i tylnego zapalenia powiek w różnych regionach, aby pomóc w zdefiniowaniu częstości i powiązania z lokalnymi czynnikami ryzyka, a także zgromadzić więcej danych do tworzenia strategii profilaktycznych.73

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Blepharitis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK459305/
    Blepharitis is not specific to any particular group, affecting individuals of all ages, ethnicities, and genders. Estimates suggest that between 37% and 47% of patients treated by eye care specialists in the United States have blepharitis, making it one of the most common ocular disorders seen in clinical practice. […] Although blepharitis can affect people of all ages and ethnic backgrounds, its prevalence tends to increase with age, likely due to the impact of the normal aging process on meibomian gland function. The condition is most commonly seen in individuals aged 50 or older. […] A major cross-sectional study conducted in Spain highlighted the prevalence of blepharitis, showing that symptomatic and asymptomatic MGD affected approximately 21.9% and 8.6% of the general population, respectively.
  • #2 Blepharitis | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/18370
    Blepharitis is not specific to any particular group, affecting individuals of all ages, ethnicities, and genders. Estimates suggest that between 37% and 47% of patients treated by eye care specialists in the United States have blepharitis, making it one of the most common ocular disorders seen in clinical practice. […] Although blepharitis can affect people of all ages and ethnic backgrounds, its prevalence tends to increase with age, likely due to the impact of the normal aging process on meibomian gland function. The condition is most commonly seen in individuals aged 50 or older. […] A major cross-sectional study conducted in Spain highlighted the prevalence of blepharitis, showing that symptomatic and asymptomatic MGD affected approximately 21.9% and 8.6% of the general population, respectively.
  • #3 Blepharitis epidemiology and demographics – wikidoc
    https://www.wikidoc.org/index.php/Blepharitis_epidemiology_and_demographics
    Blepharitis is one of the most common ocular disorders encountered in clinical practice and affects more than 180 million people in the United States. […] In the United States, blepharitis is estimated to affect more than 180 million people. […] In a United States survey of ophthalmologists and optometrists, it was estimated that 37% and 47% of the patients presented with certain form of blepharitis in clinical practice, respectively. […] The true incidence of blepharitis remains undetermined. […] Blepharitis can affect all age groups. […] A single-center study of patients with chronic blepharitis reported a mean age of 50 years. […] Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are relatively young, with a mean age of 42 years. […] Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are mostly female. […] Blepharitis can affect all ethnic groups. […] There is no racial predilection for blepharitis.
  • #4 Blepharitis prevalence and management studied in recent surveys
    https://www.ophthalmologytimes.com/view/blepharitis-prevalence-and-management-studied-recent-surveys
    Recent surveys of patients and eye care specialists were undertaken to obtain information about the prevalence and management of blepharitis. […] „Even though blepharitis is one of the most common conditions seen by eye care practitioners, there has been a shocking paucity of data in the peer-reviewed literature about its epidemiology and management,” said Dr. McDonald. […] „Extrapolating the survey prevalence data to the adult U.S. population suggests that blepharitis may affect more than 180 million people in this country.” […] A second survey queried ophthalmologists (n = 120) and optometrists (n = 84) to gain their perspectives on blepharitis prevalence, comorbidities, and management. […] Its key findings showed that the majority of patients with an ultimate diagnosis of blepharitis presented because of blepharitis or dry eye symptoms.
  • #5 Blepharitis | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/18370
    Blepharitis is not specific to any particular group, affecting individuals of all ages, ethnicities, and genders. Estimates suggest that between 37% and 47% of patients treated by eye care specialists in the United States have blepharitis, making it one of the most common ocular disorders seen in clinical practice. […] Although blepharitis can affect people of all ages and ethnic backgrounds, its prevalence tends to increase with age, likely due to the impact of the normal aging process on meibomian gland function. The condition is most commonly seen in individuals aged 50 or older. […] A major cross-sectional study conducted in Spain highlighted the prevalence of blepharitis, showing that symptomatic and asymptomatic MGD affected approximately 21.9% and 8.6% of the general population, respectively.
  • #6 Blepharitis | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/18370
    A 10-year study conducted in South Korea (2004-2013) determined the overall incidence of blepharitis to be 1.1 per 100 person-years. The incidence increased over time and was higher in female patients. The prevalence for individuals aged 40 or older was 8.8%. […] The epidemiology of blepharitis also appears to be influenced by gender. Some research suggests that women are more likely to be affected by certain subtypes of blepharitis, including staphylococcal blepharitis. For example, a single-center study found that women, with an average age of 42, comprised most patients with staphylococcal blepharitis. […] MGD and posterior blepharitis are more commonly observed in older populations, where age-related changes in glandular secretions and gland dysfunction are more prevalent. This condition, which links dermatological disorders with ocular manifestations, is also more frequently seen in populations with a higher incidence of rosacea.
  • #7 Blepharitis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK459305/
    Blepharitis is not specific to any particular group, affecting individuals of all ages, ethnicities, and genders. Estimates suggest that between 37% and 47% of patients treated by eye care specialists in the United States have blepharitis, making it one of the most common ocular disorders seen in clinical practice. […] Although blepharitis can affect people of all ages and ethnic backgrounds, its prevalence tends to increase with age, likely due to the impact of the normal aging process on meibomian gland function. The condition is most commonly seen in individuals aged 50 or older. […] A major cross-sectional study conducted in Spain highlighted the prevalence of blepharitis, showing that symptomatic and asymptomatic MGD affected approximately 21.9% and 8.6% of the general population, respectively.
  • #8 Blepharitis – EyeWiki
    https://eyewiki.org/Blepharitis
    Blepharitis is one of the most common ocular disorders encountered in clinical practice. In a survey of US ophthalmologists and optometrists, 37% to 47% of patients seen by those surveyed had signs of blepharitis. […] Apart from some regional studies, however, few epidemiologic data exists that estimate its true prevalence in the general population. A recent cross-sectional study in Spain based on a randomly selected sample population reported rates of asymptomatic and symptomatic meibomian gland dysfunction of 21.9% and 8.6% of individuals, respectively. […] Blepharitis can affect all age and ethnic groups. One single-center study of 90 patients with chronic blepharitis found that the mean age of patients was 50 years. Compared with patients with other forms of blepharitis, patients with staphylococcal blepharitis were found to be relatively younger (42 years old) and mostly female (80%).
  • #9 Blepharitis – EyeWiki
    https://eyewiki.org/Blepharitis
    Blepharitis is one of the most common ocular disorders encountered in clinical practice. In a survey of US ophthalmologists and optometrists, 37% to 47% of patients seen by those surveyed had signs of blepharitis. […] Apart from some regional studies, however, few epidemiologic data exists that estimate its true prevalence in the general population. A recent cross-sectional study in Spain based on a randomly selected sample population reported rates of asymptomatic and symptomatic meibomian gland dysfunction of 21.9% and 8.6% of individuals, respectively. […] Blepharitis can affect all age and ethnic groups. One single-center study of 90 patients with chronic blepharitis found that the mean age of patients was 50 years. Compared with patients with other forms of blepharitis, patients with staphylococcal blepharitis were found to be relatively younger (42 years old) and mostly female (80%).
  • #10 Blepharitis – EyeWiki
    https://eyewiki.org/Blepharitis
    Blepharitis is one of the most common ocular disorders encountered in clinical practice. In a survey of US ophthalmologists and optometrists, 37% to 47% of patients seen by those surveyed had signs of blepharitis. […] Apart from some regional studies, however, few epidemiologic data exists that estimate its true prevalence in the general population. A recent cross-sectional study in Spain based on a randomly selected sample population reported rates of asymptomatic and symptomatic meibomian gland dysfunction of 21.9% and 8.6% of individuals, respectively. […] Blepharitis can affect all age and ethnic groups. One single-center study of 90 patients with chronic blepharitis found that the mean age of patients was 50 years. Compared with patients with other forms of blepharitis, patients with staphylococcal blepharitis were found to be relatively younger (42 years old) and mostly female (80%).
  • #11 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #12 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #13 Blepharitis | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/18370
    A 10-year study conducted in South Korea (2004-2013) determined the overall incidence of blepharitis to be 1.1 per 100 person-years. The incidence increased over time and was higher in female patients. The prevalence for individuals aged 40 or older was 8.8%. […] The epidemiology of blepharitis also appears to be influenced by gender. Some research suggests that women are more likely to be affected by certain subtypes of blepharitis, including staphylococcal blepharitis. For example, a single-center study found that women, with an average age of 42, comprised most patients with staphylococcal blepharitis. […] MGD and posterior blepharitis are more commonly observed in older populations, where age-related changes in glandular secretions and gland dysfunction are more prevalent. This condition, which links dermatological disorders with ocular manifestations, is also more frequently seen in populations with a higher incidence of rosacea.
  • #14 Blepharitis (Remedy BNSSG ICB)
    https://remedy.bnssg.icb.nhs.uk/adults/ophthalmology/blepharitis/
    Blepharitis is an extremely common condition and can be seen in patients of any age. It is noted in 40% of routine eye examinations, found in 67% of over 60-year olds and is found in 74% of patients who complain of sore eye with screen use. […] It is linked to patients who have previous chalazia, acne rosacea, ulcerative colitis, IBS, gastritis. […] Interestingly it is more common in patients with hypercholesterolaemia and carotid stenosis, as well as anxiety and depression.
  • #15 Blepharitis (Inflamed Eyelids) | Doctor
    https://patient.info/doctor/blepharitis-pro
    Blepharitis accounts for at least 5% of ophthalmological presentations in primary care. […] The true prevalence is unknown and studies trying to estimate this have been unsatisfactory. […] All forms are equally common in both sexes, other than staphylococcal blepharitis, which is more common in women. […] Blepharitis is a condition which most commonly starts in the fourth and fifth decades of life.
  • #16 Blepharitis | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/18370
    A 10-year study conducted in South Korea (2004-2013) determined the overall incidence of blepharitis to be 1.1 per 100 person-years. The incidence increased over time and was higher in female patients. The prevalence for individuals aged 40 or older was 8.8%. […] The epidemiology of blepharitis also appears to be influenced by gender. Some research suggests that women are more likely to be affected by certain subtypes of blepharitis, including staphylococcal blepharitis. For example, a single-center study found that women, with an average age of 42, comprised most patients with staphylococcal blepharitis. […] MGD and posterior blepharitis are more commonly observed in older populations, where age-related changes in glandular secretions and gland dysfunction are more prevalent. This condition, which links dermatological disorders with ocular manifestations, is also more frequently seen in populations with a higher incidence of rosacea.
  • #17 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #18 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #19 Blepharitis (Inflamed Eyelids) | Doctor
    https://patient.info/doctor/blepharitis-pro
    Blepharitis accounts for at least 5% of ophthalmological presentations in primary care. […] The true prevalence is unknown and studies trying to estimate this have been unsatisfactory. […] All forms are equally common in both sexes, other than staphylococcal blepharitis, which is more common in women. […] Blepharitis is a condition which most commonly starts in the fourth and fifth decades of life.
  • #20 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #21 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #22 SciELO Brazil – Blefarite: epidemiologia, etiologia, apresentações clínicas, tratamento e evolução de nossos pacientes Blefarite: epidemiologia, etiologia, apresentações clínicas, tratamento e evolução de nossos pacientes
    https://www.scielo.br/j/rbof/a/3br7kD3WcVk89dDkhfTMH6M/?lang=en
    Blepharitis is one of the most commonly encountered conditions in ophthalmic practice and is a frequent cause of eye irritation and discomfort. […] The prevalence of blepharitis may vary from 37.0% to 50.0% according to some reports in the literature, most often affecting females over 50 years of age. […] By better understanding the epidemiological characteristics of blepharitis and the antimicrobial sensitivity of the bacteria involved, it is possible to offer more effective treatments. […] The aim of the present study was to identify the most prevalent epidemiological characteristics of our patients with blepharitis, the main etiological agents, clinical presentations, the best treatment, and the progression of the disease. […] Evaluation of our patients’ follow-up showed that 82.4% of patients did not return to evaluate the treatment outcome, with only 17.6% returning.
  • #23 Is Blepharitis Contagious? What You Need to Know
    https://www.healthline.com/health/eye-health/is-blepharitis-contagious
    Blepharitis is one of the most common eye conditions with studies estimating that it occurs in 37% to 50% of people at some point. Its most common in women over 50. […] Blepharitis is most common in people with certain underlying conditions. These conditions include: dandruff, rosacea, oily skin, allergies that affect your eyelashes. Its most common in women over 50 and can affect people of any gender or ethnicity. […] In a 2021 study, researchers found that people in South Korea with rosacea were more likely to have blepharitis, glaucoma, dry eyes, chalazia, and conjunctivitis (pink eye).
  • #24 Adult Blepharitis: Background, Pathophysiology, Epidemiology
    https://emedicine.medscape.com/article/1211763-overview
    Blepharitis is a common eye disorder in the United States and throughout the world. Based on Lemp et als estimate that 86% of all patients with dry eyes have concomitant blepharitis, more than 25 million Americans suffer from blepharitis. […] The exact association between blepharitis and mortality is not known, but diseases with known mortality, such as systemic lupus erythematosus, may have blepharitis as part of their constellation of findings. Associated morbidity includes loss of visual function, well-being, and ability to carry out daily life activities. […] No known studies demonstrate racial differences in the incidence of blepharitis. […] No well-designed studies of differences in the incidence and clinical features of blepharitis between the sexes have been found. […] Seborrheic blepharitis is more common in an older age group. The apparent mean age is 50 years.
  • #25 Blepharitis epidemiology and demographics – wikidoc
    https://www.wikidoc.org/index.php/Blepharitis_epidemiology_and_demographics
    Blepharitis is one of the most common ocular disorders encountered in clinical practice and affects more than 180 million people in the United States. […] In the United States, blepharitis is estimated to affect more than 180 million people. […] In a United States survey of ophthalmologists and optometrists, it was estimated that 37% and 47% of the patients presented with certain form of blepharitis in clinical practice, respectively. […] The true incidence of blepharitis remains undetermined. […] Blepharitis can affect all age groups. […] A single-center study of patients with chronic blepharitis reported a mean age of 50 years. […] Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are relatively young, with a mean age of 42 years. […] Compared with other forms of blepharitis, patients affected by staphylococcal blepharitis are mostly female. […] Blepharitis can affect all ethnic groups. […] There is no racial predilection for blepharitis.
  • #26
    https://journals.lww.com/pajo/fulltext/2023/08310/prevalence_of_blepharitis_in_adult_patients_in.30.aspx
    In this study, the prevalence of blepharitis in adult patients that consulted with eye care specialists at the Fundacin Oftalmolgica Nacional between July and October 2021 was 68%. The most frequent type was posterior blepharitis in 55.8% of patients, followed by marginal blepharitis in 31.6%, and anterior blepharitis in 12.6%. […] The considerable overlapping of symptoms and signs with other pathologies, such as dry eye or allergic conjunctivitis, leads to confusion when establishing a primary diagnosis. This overlapping of symptoms ultimately masks blepharitis as the underlying pathology leaving it untreated, while treatment focuses solely on allergic and dry eye symptoms. […] There is a clear need for prevalence studies of anterior, marginal, and posterior blepharitis in the region to help us define frequency and association with local risk factors as well as more data to create prevention strategies. […] However, the prevalence and the characteristics of the pathology found suggest blepharitis is being overlooked and underdiagnosed, and therefore, left untreated, affecting the quality of life of many patients.
  • #27 Blepharitis – EyeWiki
    https://eyewiki.org/Blepharitis
    Blepharitis is one of the most common ocular disorders encountered in clinical practice. In a survey of US ophthalmologists and optometrists, 37% to 47% of patients seen by those surveyed had signs of blepharitis. […] Apart from some regional studies, however, few epidemiologic data exists that estimate its true prevalence in the general population. A recent cross-sectional study in Spain based on a randomly selected sample population reported rates of asymptomatic and symptomatic meibomian gland dysfunction of 21.9% and 8.6% of individuals, respectively. […] Blepharitis can affect all age and ethnic groups. One single-center study of 90 patients with chronic blepharitis found that the mean age of patients was 50 years. Compared with patients with other forms of blepharitis, patients with staphylococcal blepharitis were found to be relatively younger (42 years old) and mostly female (80%).
  • #28 Blepharitis prevalence and management studied in recent surveys
    https://www.ophthalmologytimes.com/view/blepharitis-prevalence-and-management-studied-recent-surveys
    Recent surveys of patients and eye care specialists were undertaken to obtain information about the prevalence and management of blepharitis. […] „Even though blepharitis is one of the most common conditions seen by eye care practitioners, there has been a shocking paucity of data in the peer-reviewed literature about its epidemiology and management,” said Dr. McDonald. […] „Extrapolating the survey prevalence data to the adult U.S. population suggests that blepharitis may affect more than 180 million people in this country.” […] A second survey queried ophthalmologists (n = 120) and optometrists (n = 84) to gain their perspectives on blepharitis prevalence, comorbidities, and management. […] Its key findings showed that the majority of patients with an ultimate diagnosis of blepharitis presented because of blepharitis or dry eye symptoms.
  • #29
    https://journals.lww.com/pajo/fulltext/2023/08310/prevalence_of_blepharitis_in_adult_patients_in.30.aspx
    In this study, the prevalence of blepharitis in adult patients that consulted with eye care specialists at the Fundacin Oftalmolgica Nacional between July and October 2021 was 68%. The most frequent type was posterior blepharitis in 55.8% of patients, followed by marginal blepharitis in 31.6%, and anterior blepharitis in 12.6%. […] The considerable overlapping of symptoms and signs with other pathologies, such as dry eye or allergic conjunctivitis, leads to confusion when establishing a primary diagnosis. This overlapping of symptoms ultimately masks blepharitis as the underlying pathology leaving it untreated, while treatment focuses solely on allergic and dry eye symptoms. […] There is a clear need for prevalence studies of anterior, marginal, and posterior blepharitis in the region to help us define frequency and association with local risk factors as well as more data to create prevention strategies. […] However, the prevalence and the characteristics of the pathology found suggest blepharitis is being overlooked and underdiagnosed, and therefore, left untreated, affecting the quality of life of many patients.
  • #30 Unmet Needs in the Management of Demodex Blepharitis
    https://www.ajmc.com/view/unmet-needs-in-the-management-of-demodex-blepharitis
    Demodex blepharitis is a common inflammatory eye condition involving the skin, eyelashes, lash follicles, and sebaceous glands that is often overlooked. […] Despite its worldwide prevalence, Demodex blepharitis remains largely underdiagnosed and underappreciated. […] Studies of the incidence of Demodex blepharitis in the US population are limited. […] Additional estimates of worldwide prevalence of Demodex blepharitis exist, but vary widely. […] Several studies reported a higher prevalence of Demodex blepharitis in older adults. […] A search of MEDLINE, PubMed, EBSCO, Cochrane, PROQUEST, and Google Scholar in June 2022 revealed that there were no known studies measuring Demodex blepharitis in commercial insurance, Medicare, or Medicaid databases. […] The paucity of research on the epidemiology of Demodex blepharitis is reflected in a lack of routine screening for Demodex mites and a lack of standardized criteria for diagnosing the disease. […] Current management options include products containing tea tree oil, terpinen-4-ol, and/or linalool; however, use of these products may not fully eradicate mites, may only partially relieve symptoms, and may cause irritation.
  • #31 Unmet Needs in the Management of Demodex Blepharitis
    https://www.ajmc.com/view/unmet-needs-in-the-management-of-demodex-blepharitis
    Demodex blepharitis is a common inflammatory eye condition involving the skin, eyelashes, lash follicles, and sebaceous glands that is often overlooked. […] Despite its worldwide prevalence, Demodex blepharitis remains largely underdiagnosed and underappreciated. […] Studies of the incidence of Demodex blepharitis in the US population are limited. […] Additional estimates of worldwide prevalence of Demodex blepharitis exist, but vary widely. […] Several studies reported a higher prevalence of Demodex blepharitis in older adults. […] A search of MEDLINE, PubMed, EBSCO, Cochrane, PROQUEST, and Google Scholar in June 2022 revealed that there were no known studies measuring Demodex blepharitis in commercial insurance, Medicare, or Medicaid databases. […] The paucity of research on the epidemiology of Demodex blepharitis is reflected in a lack of routine screening for Demodex mites and a lack of standardized criteria for diagnosing the disease. […] Current management options include products containing tea tree oil, terpinen-4-ol, and/or linalool; however, use of these products may not fully eradicate mites, may only partially relieve symptoms, and may cause irritation.
  • #32 SciELO Brazil – Blefarite: epidemiologia, etiologia, apresentações clínicas, tratamento e evolução de nossos pacientes Blefarite: epidemiologia, etiologia, apresentações clínicas, tratamento e evolução de nossos pacientes
    https://www.scielo.br/j/rbof/a/3br7kD3WcVk89dDkhfTMH6M/?lang=en
    Blepharitis is one of the most commonly encountered conditions in ophthalmic practice and is a frequent cause of eye irritation and discomfort. […] The prevalence of blepharitis may vary from 37.0% to 50.0% according to some reports in the literature, most often affecting females over 50 years of age. […] By better understanding the epidemiological characteristics of blepharitis and the antimicrobial sensitivity of the bacteria involved, it is possible to offer more effective treatments. […] The aim of the present study was to identify the most prevalent epidemiological characteristics of our patients with blepharitis, the main etiological agents, clinical presentations, the best treatment, and the progression of the disease. […] Evaluation of our patients’ follow-up showed that 82.4% of patients did not return to evaluate the treatment outcome, with only 17.6% returning.
  • #33 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #34 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #35 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #36 Epidemiology – Primary Care Notebook
    https://primarycarenotebook.com/pages/ophthalmology/blepharitis/epidemiology
    One of the most common ocular disorders encountered by ophthalmologists. […] Epidemiologic information on its incidence or prevalence is lacking. […] According to the data of studies carried out regarding blepharitis: staphylococcal blepharitis average age of onset was around 42 years more common in women 25% to 50% of patients had keratoconjunctivitis sicca (KCS, or dry eye syndrome). […] seborrhoeic blepharitis average age of patients was around 50 years prevalence was equal between men and women 95% of patients had seborrhoeic blepharitis while 25-40% had KCS. […] meibomian gland disease (MGD) mean age of onset was around 50 years equally common between men and women 20% of MGD patients had acne rosacea and 46% had seborrhoeic dermatitis.
  • #37 Adult Blepharitis: Background, Pathophysiology, Epidemiology
    https://emedicine.medscape.com/article/1211763-overview
    Blepharitis is a common eye disorder in the United States and throughout the world. Based on Lemp et als estimate that 86% of all patients with dry eyes have concomitant blepharitis, more than 25 million Americans suffer from blepharitis. […] The exact association between blepharitis and mortality is not known, but diseases with known mortality, such as systemic lupus erythematosus, may have blepharitis as part of their constellation of findings. Associated morbidity includes loss of visual function, well-being, and ability to carry out daily life activities. […] No known studies demonstrate racial differences in the incidence of blepharitis. […] No well-designed studies of differences in the incidence and clinical features of blepharitis between the sexes have been found. […] Seborrheic blepharitis is more common in an older age group. The apparent mean age is 50 years.
  • #38 Blepharitis (Remedy BNSSG ICB)
    https://remedy.bnssg.icb.nhs.uk/adults/ophthalmology/blepharitis/
    Blepharitis is an extremely common condition and can be seen in patients of any age. It is noted in 40% of routine eye examinations, found in 67% of over 60-year olds and is found in 74% of patients who complain of sore eye with screen use. […] It is linked to patients who have previous chalazia, acne rosacea, ulcerative colitis, IBS, gastritis. […] Interestingly it is more common in patients with hypercholesterolaemia and carotid stenosis, as well as anxiety and depression.
  • #39 Blepharitis (Remedy BNSSG ICB)
    https://remedy.bnssg.icb.nhs.uk/adults/ophthalmology/blepharitis/
    Blepharitis is an extremely common condition and can be seen in patients of any age. It is noted in 40% of routine eye examinations, found in 67% of over 60-year olds and is found in 74% of patients who complain of sore eye with screen use. […] It is linked to patients who have previous chalazia, acne rosacea, ulcerative colitis, IBS, gastritis. […] Interestingly it is more common in patients with hypercholesterolaemia and carotid stenosis, as well as anxiety and depression.
  • #40 Blepharitis (Remedy BNSSG ICB)
    https://remedy.bnssg.icb.nhs.uk/adults/ophthalmology/blepharitis/
    Blepharitis is an extremely common condition and can be seen in patients of any age. It is noted in 40% of routine eye examinations, found in 67% of over 60-year olds and is found in 74% of patients who complain of sore eye with screen use. […] It is linked to patients who have previous chalazia, acne rosacea, ulcerative colitis, IBS, gastritis. […] Interestingly it is more common in patients with hypercholesterolaemia and carotid stenosis, as well as anxiety and depression.
  • #41 Patients with Blepharitis Are at Elevated Risk of Anxiety and Depression | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083335
    Population-based cohort study on the risk of anxiety and depression in patients with blepharitis is limited. This study evaluated whether blepharitis patients are at a higher risk of anxiety and depression. […] Compared with the non-blepharitis cohort, the blepharitis cohort had higher incidence of anxiety (15.9 vs. 9.5 per 1000 person-years), with an adjusted HR of 1.58 (95% confidence interval (CI)=1.461.70). The incidence of depression was also higher in the blepharitis cohort (7.66 vs. 5.05 per 1000 person-years), with an adjusted HR of 1.42 (95% CI=1.281.58). […] Patients with blepharitis are at elevated risks of anxiety and depression. The risk is higher in earlier period after the diagnosis of blepharitis, and declines by time, but remains significantly higher for those with blepharitis than those without blepharitis.
  • #42
    https://www.healio.com/news/optometry/20130906/10_3928_1081_597x_20130101_00_1309373
    Cases of anterior blepharitis that do not resolve with antibiotics may actually be caused by Demodex mites, which are much more prevalent than generally thought. […] According to a recent case report series published in Optometry and Vision Science, Demodex folliculorum and Demodex brevis can be found in 20% to 80% of all people, the prevalence increasing with age. […] In fact, the ectoparasites have a prevalence of 100% once a patient reaches 70 years of age and older, according to the study. […] Supporting this claim, a study published in Ophthalmic Epidemiology in 2012 found that meta-analysis can confirm the association between Demodex infestation and blepharitis. […] According to the study results, the pooled odds ratio, used as the effect indicator, was 4.89, and the sensitivity analysis showed that the results of these pooled odds ratios in different effect models, language, sample size and control groups were completely consistent. This demonstrated a statistically significant association between Demodex and blepharitis. […] The conclusion implies that when conventional treatments for blepharitis fail, examination of Demodex mites and acaricidal therapy should be considered, the study authors said.
  • #43
    https://www.healio.com/news/optometry/20130906/10_3928_1081_597x_20130101_00_1309373
    Cases of anterior blepharitis that do not resolve with antibiotics may actually be caused by Demodex mites, which are much more prevalent than generally thought. […] According to a recent case report series published in Optometry and Vision Science, Demodex folliculorum and Demodex brevis can be found in 20% to 80% of all people, the prevalence increasing with age. […] In fact, the ectoparasites have a prevalence of 100% once a patient reaches 70 years of age and older, according to the study. […] Supporting this claim, a study published in Ophthalmic Epidemiology in 2012 found that meta-analysis can confirm the association between Demodex infestation and blepharitis. […] According to the study results, the pooled odds ratio, used as the effect indicator, was 4.89, and the sensitivity analysis showed that the results of these pooled odds ratios in different effect models, language, sample size and control groups were completely consistent. This demonstrated a statistically significant association between Demodex and blepharitis. […] The conclusion implies that when conventional treatments for blepharitis fail, examination of Demodex mites and acaricidal therapy should be considered, the study authors said.
  • #44 CRST Global | Blepharitis and Demodex
    https://crstodayeurope.com/articles/issue01-2025/blepharitis-and-demodex/
    Blepharitis is a multifactorial condition with diverse clinical presentations, including lash debris and meibomian gland dysfunction (MGD). Its etiologies include allergies, staphylococcal infection, seborrheic dermatitis, rosacea, and Demodex infestation. The association between blepharitis and Demodex was first described in 1959, and it remains well supported. A 2020 meta-analysis identified ocular Demodex in 29% to 90% of individuals with symptomatic blepharitis. The mites are more common in patients with blepharitis than in those without the condition (odds ratio, 2.5). […] DB affects patients of both sexes and all ethnicities. In a cross-sectional study of adults in South Florida (n = 119), DB was identified in 72%, 65%, and 69% of White, Black, and Hispanic individuals, respectively. The frequency of DB increases with age. A Polish hospital-based study of 435 patients identified DB in 95% of individuals 71 years of age or older, 87% of those 51 to 70 years of age, and 13% of those 3 to 15 years of age. Similar findings were reported in another Polish hospital-based study of 1,499 patients, which identified DB in 77% of individuals 70 years of age or older and 8% of those 25 years of age or younger.
  • #45 CRST Global | Blepharitis and Demodex
    https://crstodayeurope.com/articles/issue01-2025/blepharitis-and-demodex/
    Blepharitis is a multifactorial condition with diverse clinical presentations, including lash debris and meibomian gland dysfunction (MGD). Its etiologies include allergies, staphylococcal infection, seborrheic dermatitis, rosacea, and Demodex infestation. The association between blepharitis and Demodex was first described in 1959, and it remains well supported. A 2020 meta-analysis identified ocular Demodex in 29% to 90% of individuals with symptomatic blepharitis. The mites are more common in patients with blepharitis than in those without the condition (odds ratio, 2.5). […] DB affects patients of both sexes and all ethnicities. In a cross-sectional study of adults in South Florida (n = 119), DB was identified in 72%, 65%, and 69% of White, Black, and Hispanic individuals, respectively. The frequency of DB increases with age. A Polish hospital-based study of 435 patients identified DB in 95% of individuals 71 years of age or older, 87% of those 51 to 70 years of age, and 13% of those 3 to 15 years of age. Similar findings were reported in another Polish hospital-based study of 1,499 patients, which identified DB in 77% of individuals 70 years of age or older and 8% of those 25 years of age or younger.
  • #46 CRST Global | Blepharitis and Demodex
    https://crstodayeurope.com/articles/issue01-2025/blepharitis-and-demodex/
    DB is uncommon in pediatric patients but is more prevalent among children with specific risk factors. A multisite (United States and China) study conducted in hospitals and private practices reported a 12% prevalence of DB among healthy children (n = 1,575; 3-14 years of age). The frequency was higher among immunocompromised children (n = 131), particularly those who were malnourished (25%) or had cancer (32%).
  • #47
    https://www.healio.com/news/optometry/20130906/10_3928_1081_597x_20130101_00_1309373
    Cases of anterior blepharitis that do not resolve with antibiotics may actually be caused by Demodex mites, which are much more prevalent than generally thought. […] According to a recent case report series published in Optometry and Vision Science, Demodex folliculorum and Demodex brevis can be found in 20% to 80% of all people, the prevalence increasing with age. […] In fact, the ectoparasites have a prevalence of 100% once a patient reaches 70 years of age and older, according to the study. […] Supporting this claim, a study published in Ophthalmic Epidemiology in 2012 found that meta-analysis can confirm the association between Demodex infestation and blepharitis. […] According to the study results, the pooled odds ratio, used as the effect indicator, was 4.89, and the sensitivity analysis showed that the results of these pooled odds ratios in different effect models, language, sample size and control groups were completely consistent. This demonstrated a statistically significant association between Demodex and blepharitis. […] The conclusion implies that when conventional treatments for blepharitis fail, examination of Demodex mites and acaricidal therapy should be considered, the study authors said.
  • #48
    https://www.archivesofmedicalscience.com/The-impact-of-age-sex-blepharitis-rosacea-and-rheumatoid-arthritis-on-Demodex-mite,59398,0,2.html
    Demodex sp. infection was revealed in 47% of patients (487 women and 216 men). […] Patients suffering from blepharitis were found to have a nearly 2.5-fold higher risk of Demodex infection than those without blepharitis, and the risk for rosacea patients was determined as three-fold higher than that of the general population. […] Blepharitis and rosacea are risk factors for Demodex infection.
  • #49 Unmet Needs in the Management of Demodex Blepharitis
    https://www.ajmc.com/view/unmet-needs-in-the-management-of-demodex-blepharitis
    Demodex blepharitis is a common inflammatory eye condition involving the skin, eyelashes, lash follicles, and sebaceous glands that is often overlooked. […] Despite its worldwide prevalence, Demodex blepharitis remains largely underdiagnosed and underappreciated. […] Studies of the incidence of Demodex blepharitis in the US population are limited. […] Additional estimates of worldwide prevalence of Demodex blepharitis exist, but vary widely. […] Several studies reported a higher prevalence of Demodex blepharitis in older adults. […] A search of MEDLINE, PubMed, EBSCO, Cochrane, PROQUEST, and Google Scholar in June 2022 revealed that there were no known studies measuring Demodex blepharitis in commercial insurance, Medicare, or Medicaid databases. […] The paucity of research on the epidemiology of Demodex blepharitis is reflected in a lack of routine screening for Demodex mites and a lack of standardized criteria for diagnosing the disease. […] Current management options include products containing tea tree oil, terpinen-4-ol, and/or linalool; however, use of these products may not fully eradicate mites, may only partially relieve symptoms, and may cause irritation.
  • #50 Diagnose that Disease: Blepharitis
    https://www.reviewofcontactlenses.com/article/diagnose-that-disease-blepharitis
    Blepharitis is one of the most frequently observed conditions among eye care practitioners, yet remains largely misunderstood. Reports show that up to 47% of patients seen by optometrists in clinical practice show symptoms consistent with blepharitis, and 79% of the general population has experienced at least one symptom of blepharitis in the last 12 months. […] Despite this high prevalence, there are no well-controlled clinical trials that support FDA approval for topical agents of either anterior or posterior blepharitis, which presents a frustrating conundrum for eye doctors and the patients they treat. […] Evaluating drug treatments for blepharitis has become a priority in the last decade, with several studies emerging in support of a combined antibiotic and steroid therapy. […] Growing awareness of the prevalence of this disease, particularly in the last decade, has led the eye care community to prioritize research into consensual etiologies and effective therapeutic treatments.
  • #51 Blepharitis Market Size, Trends and Forecast 2024-2034
    https://www.imarcgroup.com/blepharitis-market
    The blepharitis market has been comprehensively analyzed in IMARC’s new report titled „Blepharitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034”. […] The rising prevalence of bacterial infections due to trauma, eye surgery, immune deficiencies, etc., is primarily driving the blepharitis market. […] IMARC Group’s new report provides an exhaustive analysis of the blepharitis market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. […] According to the report the United States has the largest patient pool for blepharitis and also represents the largest market for its treatment.
  • #52 Blepharitis Market Outlook and Forecast – Thelansis
    https://thelansis.com/reports/blepharitis-market-outlook-forecast/
    The prevalence of Blepharitis may vary from 27.0% to 35.0% adult population. Females accounted for 60% of cases and males for 40%. Regarding the severity of the disease, more than half were diagnosed with mild blepharitis 55% to 57.8% and 40% to 42.6% cases diagnosed with moderate, and 1.6% to 3.5% as severe. […] KOLs across 8 MM markets from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. […] Blepharitis Epidemiology in US (2021-2032) […] Blepharitis Epidemiology in EU-5 (2021-2032) […] Blepharitis Epidemiology in Japan (2021-2032) […] Blepharitis Epidemiology in China (2021-2032) […] Epidemiology Trends (World-wide)
  • #53 Blepharitis Market Size, Trends and Forecast 2024-2034
    https://www.imarcgroup.com/blepharitis-market
    The blepharitis market has been comprehensively analyzed in IMARC’s new report titled „Blepharitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034”. […] The rising prevalence of bacterial infections due to trauma, eye surgery, immune deficiencies, etc., is primarily driving the blepharitis market. […] IMARC Group’s new report provides an exhaustive analysis of the blepharitis market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. […] According to the report the United States has the largest patient pool for blepharitis and also represents the largest market for its treatment.
  • #54 Blepharitis Market Outlook and Forecast – Thelansis
    https://thelansis.com/reports/blepharitis-market-outlook-forecast/
    The prevalence of Blepharitis may vary from 27.0% to 35.0% adult population. Females accounted for 60% of cases and males for 40%. Regarding the severity of the disease, more than half were diagnosed with mild blepharitis 55% to 57.8% and 40% to 42.6% cases diagnosed with moderate, and 1.6% to 3.5% as severe. […] KOLs across 8 MM markets from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. […] Blepharitis Epidemiology in US (2021-2032) […] Blepharitis Epidemiology in EU-5 (2021-2032) […] Blepharitis Epidemiology in Japan (2021-2032) […] Blepharitis Epidemiology in China (2021-2032) […] Epidemiology Trends (World-wide)
  • #55 Blepharitis Market Outlook and Forecast – Thelansis
    https://thelansis.com/reports/blepharitis-market-outlook-forecast/
    The prevalence of Blepharitis may vary from 27.0% to 35.0% adult population. Females accounted for 60% of cases and males for 40%. Regarding the severity of the disease, more than half were diagnosed with mild blepharitis 55% to 57.8% and 40% to 42.6% cases diagnosed with moderate, and 1.6% to 3.5% as severe. […] KOLs across 8 MM markets from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. […] Blepharitis Epidemiology in US (2021-2032) […] Blepharitis Epidemiology in EU-5 (2021-2032) […] Blepharitis Epidemiology in Japan (2021-2032) […] Blepharitis Epidemiology in China (2021-2032) […] Epidemiology Trends (World-wide)
  • #56 Content Engine LLC.
    https://contentenginellc.com/2022/02/08/blepharitis-market-insight-epidemiology-competitive-landscape-and-market-forecast-report-2020-to-2030/
    According to a literature survey, The prevalence of Blepharitis may vary from 37.0% to 50.0?cording to some reports in the literature, most often affecting females over 50 years of age. Females accounted for 55% to 60% of cases, and males for 40% to 45%. […] Comprehensive insight on patient segmentation based on age, sex, Types (anterior blepharitis posterior blepharitis), the severity of infection (Acute Chronic), Risk factors (Dry eye, Dermatologic conditions, Demodicosis, Rosacea, Isotretinoin, Giant papillary conjunctivitis Others), Stages (mild, moderate Severe) Signs Symptoms, Clinical Manifestations, Treatment types (Antibiotics; Topical and systemic, anti-inflammatory agents and Others) has been provided into the epidemiology section of the Blepharitis and its treatment in the 8 MM countries, covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan, and China.
  • #57 Adult Blepharitis: Background, Pathophysiology, Epidemiology
    https://emedicine.medscape.com/article/1211763-overview
    Blepharitis is a common eye disorder in the United States and throughout the world. Based on Lemp et als estimate that 86% of all patients with dry eyes have concomitant blepharitis, more than 25 million Americans suffer from blepharitis. […] The exact association between blepharitis and mortality is not known, but diseases with known mortality, such as systemic lupus erythematosus, may have blepharitis as part of their constellation of findings. Associated morbidity includes loss of visual function, well-being, and ability to carry out daily life activities. […] No known studies demonstrate racial differences in the incidence of blepharitis. […] No well-designed studies of differences in the incidence and clinical features of blepharitis between the sexes have been found. […] Seborrheic blepharitis is more common in an older age group. The apparent mean age is 50 years.
  • #58 Patients with Blepharitis Are at Elevated Risk of Anxiety and Depression | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083335
    Population-based cohort study on the risk of anxiety and depression in patients with blepharitis is limited. This study evaluated whether blepharitis patients are at a higher risk of anxiety and depression. […] Compared with the non-blepharitis cohort, the blepharitis cohort had higher incidence of anxiety (15.9 vs. 9.5 per 1000 person-years), with an adjusted HR of 1.58 (95% confidence interval (CI)=1.461.70). The incidence of depression was also higher in the blepharitis cohort (7.66 vs. 5.05 per 1000 person-years), with an adjusted HR of 1.42 (95% CI=1.281.58). […] Patients with blepharitis are at elevated risks of anxiety and depression. The risk is higher in earlier period after the diagnosis of blepharitis, and declines by time, but remains significantly higher for those with blepharitis than those without blepharitis.
  • #59 Patients with Blepharitis Are at Elevated Risk of Anxiety and Depression | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0083335
    The incidence rate of anxiety was 1.67-fold higher in the blepharitis cohort than in the non-blepharitis cohort (15.9 vs. 9.5 per 1000 person-years), with an adjusted HRs of 1.58 (95% CI=1.461.70). So was the incidence of depression 1.52-fold higher in the blepharitis cohort (7.66 vs. 5.05 per 1000 person-years), with an adjusted HRs of 1.42 (95% CI=1.281.58). […] The comorbidity specific analysis in the multivariable Cox proportional hazards regression model showed consistently higher incidence rates of anxiety and depression in the blepharitis cohort than in the non-blepharitis cohort. […] The present study shows patients with blepharitis are at higher risk of anxiety or depression.
  • #60 Blepharitis – EyeWiki
    https://eyewiki.org/Blepharitis
    Blepharitis is one of the most common ocular disorders encountered in clinical practice. In a survey of US ophthalmologists and optometrists, 37% to 47% of patients seen by those surveyed had signs of blepharitis. […] Apart from some regional studies, however, few epidemiologic data exists that estimate its true prevalence in the general population. A recent cross-sectional study in Spain based on a randomly selected sample population reported rates of asymptomatic and symptomatic meibomian gland dysfunction of 21.9% and 8.6% of individuals, respectively. […] Blepharitis can affect all age and ethnic groups. One single-center study of 90 patients with chronic blepharitis found that the mean age of patients was 50 years. Compared with patients with other forms of blepharitis, patients with staphylococcal blepharitis were found to be relatively younger (42 years old) and mostly female (80%).
  • #61 Blepharitis: epidemiology, etiology, clinical presentations, treatment and evolution of our patients – Revista Brasileira de Oftalmologia
    https://www.rbojournal.org/en/article/blepharitis-epidemiology-etiology-clinical-presentations-treatment-and-evolution-of-our-patients/
    Blepharitis is one of the most commonly encountered conditions in ophthalmic practice and is a frequent cause of eye irritation and discomfort. […] By better understanding the epidemiological characteristics of blepharitis and the antimicrobial sensitivity of the bacteria involved, it is possible to offer more effective treatments.
  • #62 Treating Blepharitis: Annoying Condition for Patients, Vocabulary Builder for Pharmacists
    https://www.pharmacytimes.com/view/treating-blepharitis-annoying-condition-for-patients-vocabulary-builder-for-pharmacists
    Eye irritation is among the most common and most annoying conditions for patients. For approximately 20% to 40% of Americans, these signs usually indicate bilateral blepharitis. […] Incidence seems to increase with age, but younger people appear to be more bothered by the symptoms than elders. […] Blepharitis is frequently associated with systemic diseases. […] Approximately 15% of patients have symptoms about half the time. […] Although far from life-threatening, blepharitis impact can be significant. […] The normal progression may include eyelid damage to the lids with trichiasis, or entropion and ectropion (respectively, inward or outward turning lids that cannot close properly). […] Ophthalmologists and opticians encourage blepharitis sufferers to establish a systematic, long-term commitment to eyelid hygiene, because management will require lifelong vigilance.
  • #63 Understanding Demodex Blepharitis: Symptoms, Treatments, and Epidemiology – Burman & Zuckerbrod Ophthalmology Associates
    https://www.2020detroit.com/understanding-demodex-blepharitis-symptoms-treatments-and-epidemiology/
    Demodex mites are ubiquitous and generally harmless in small numbers. However, certain factors can lead to their overgrowth. Research indicates that the prevalence of Demodex blepharitis increases with age, affecting up to 84% of individuals over 60 years old. […] With the aging population, the incidence of demodex blepharitis is likely to rise, making awareness and effective management essential. […] In conclusion, demodex blepharitis is a prevalent yet manageable condition that can significantly affect ones quality of life. Understanding its symptoms, recognizing risk factors, and following appropriate treatment protocols including new options like Xdemvy are key to effective management.
  • #64
    https://journals.lww.com/pajo/fulltext/2023/08310/prevalence_of_blepharitis_in_adult_patients_in.30.aspx
    In this study, the prevalence of blepharitis in adult patients that consulted with eye care specialists at the Fundacin Oftalmolgica Nacional between July and October 2021 was 68%. The most frequent type was posterior blepharitis in 55.8% of patients, followed by marginal blepharitis in 31.6%, and anterior blepharitis in 12.6%. […] The considerable overlapping of symptoms and signs with other pathologies, such as dry eye or allergic conjunctivitis, leads to confusion when establishing a primary diagnosis. This overlapping of symptoms ultimately masks blepharitis as the underlying pathology leaving it untreated, while treatment focuses solely on allergic and dry eye symptoms. […] There is a clear need for prevalence studies of anterior, marginal, and posterior blepharitis in the region to help us define frequency and association with local risk factors as well as more data to create prevention strategies. […] However, the prevalence and the characteristics of the pathology found suggest blepharitis is being overlooked and underdiagnosed, and therefore, left untreated, affecting the quality of life of many patients.
  • #65 Understanding Demodex Blepharitis: Symptoms, Treatments, and Epidemiology – Burman & Zuckerbrod Ophthalmology Associates
    https://www.2020detroit.com/understanding-demodex-blepharitis-symptoms-treatments-and-epidemiology/
    Demodex mites are ubiquitous and generally harmless in small numbers. However, certain factors can lead to their overgrowth. Research indicates that the prevalence of Demodex blepharitis increases with age, affecting up to 84% of individuals over 60 years old. […] With the aging population, the incidence of demodex blepharitis is likely to rise, making awareness and effective management essential. […] In conclusion, demodex blepharitis is a prevalent yet manageable condition that can significantly affect ones quality of life. Understanding its symptoms, recognizing risk factors, and following appropriate treatment protocols including new options like Xdemvy are key to effective management.
  • #66 Diagnose that Disease: Blepharitis
    https://www.reviewofcontactlenses.com/article/diagnose-that-disease-blepharitis
    Blepharitis is one of the most frequently observed conditions among eye care practitioners, yet remains largely misunderstood. Reports show that up to 47% of patients seen by optometrists in clinical practice show symptoms consistent with blepharitis, and 79% of the general population has experienced at least one symptom of blepharitis in the last 12 months. […] Despite this high prevalence, there are no well-controlled clinical trials that support FDA approval for topical agents of either anterior or posterior blepharitis, which presents a frustrating conundrum for eye doctors and the patients they treat. […] Evaluating drug treatments for blepharitis has become a priority in the last decade, with several studies emerging in support of a combined antibiotic and steroid therapy. […] Growing awareness of the prevalence of this disease, particularly in the last decade, has led the eye care community to prioritize research into consensual etiologies and effective therapeutic treatments.
  • #67 Treating Blepharitis: Annoying Condition for Patients, Vocabulary Builder for Pharmacists
    https://www.pharmacytimes.com/view/treating-blepharitis-annoying-condition-for-patients-vocabulary-builder-for-pharmacists
    Hygienic measures rarely cure blepharitis. […] Blepharitis that is related to a generalized seborrheic component often clears somewhat as the condition responds to selenium shampoos on the hair and skin, but not on the eyes. […] Some researchers have used the broad-spectrum antiparasitic ivermectin to reduce the number of D folliculorum mites found in the lashes. […] Recently, several researchers have found that blepharitis and dry eye syndromes may improve with lid scrubs formulated with 50% tea tree (melaleuca) oil.
  • #68 Blepharitis – What is it, Causes and Treatment
    https://plano.co/eye-conditions/other-eye-conditions/blepharitis/
    Poor compliance to treatment is a major reason why blepharitis can reoccur. Studies have shown that only half of the people who start treatments to keep their lids clean continue to do so after six weeks. It is important that the treatment that is recommended by an eye health professional is maintained to prevent blepharitis from reoccurring.
  • #69 Unmet Needs in the Management of Demodex Blepharitis
    https://www.ajmc.com/view/unmet-needs-in-the-management-of-demodex-blepharitis
    Demodex blepharitis is a common inflammatory eye condition involving the skin, eyelashes, lash follicles, and sebaceous glands that is often overlooked. […] Despite its worldwide prevalence, Demodex blepharitis remains largely underdiagnosed and underappreciated. […] Studies of the incidence of Demodex blepharitis in the US population are limited. […] Additional estimates of worldwide prevalence of Demodex blepharitis exist, but vary widely. […] Several studies reported a higher prevalence of Demodex blepharitis in older adults. […] A search of MEDLINE, PubMed, EBSCO, Cochrane, PROQUEST, and Google Scholar in June 2022 revealed that there were no known studies measuring Demodex blepharitis in commercial insurance, Medicare, or Medicaid databases. […] The paucity of research on the epidemiology of Demodex blepharitis is reflected in a lack of routine screening for Demodex mites and a lack of standardized criteria for diagnosing the disease. […] Current management options include products containing tea tree oil, terpinen-4-ol, and/or linalool; however, use of these products may not fully eradicate mites, may only partially relieve symptoms, and may cause irritation.
  • #70 Blepharitis – Pathway
    https://m.pathway.md/diseases/blepharitis-rec6OLM39Q041Xaqa
    The prevalence of blepharitis in ophthalmological and optometric practice is reported at 37% and 47%, respectively. […] Follow-up: as per AAO 2022 guidelines, arrange follow-up visits to elicit interval history, measure visual acuity, perform external physical examinations, and obtain slit-lamp biomicroscopy.
  • #71 Blepharitis: epidemiology, etiology, clinical presentations, treatment and evolution of our patients – Revista Brasileira de Oftalmologia
    https://www.rbojournal.org/en/article/blepharitis-epidemiology-etiology-clinical-presentations-treatment-and-evolution-of-our-patients/
    Blepharitis is one of the most commonly encountered conditions in ophthalmic practice and is a frequent cause of eye irritation and discomfort. […] By better understanding the epidemiological characteristics of blepharitis and the antimicrobial sensitivity of the bacteria involved, it is possible to offer more effective treatments.
  • #72 SciELO Brazil – Blefarite: epidemiologia, etiologia, apresentações clínicas, tratamento e evolução de nossos pacientes Blefarite: epidemiologia, etiologia, apresentações clínicas, tratamento e evolução de nossos pacientes
    https://www.scielo.br/j/rbof/a/3br7kD3WcVk89dDkhfTMH6M/?lang=en
    Blepharitis is one of the most commonly encountered conditions in ophthalmic practice and is a frequent cause of eye irritation and discomfort. […] The prevalence of blepharitis may vary from 37.0% to 50.0% according to some reports in the literature, most often affecting females over 50 years of age. […] By better understanding the epidemiological characteristics of blepharitis and the antimicrobial sensitivity of the bacteria involved, it is possible to offer more effective treatments. […] The aim of the present study was to identify the most prevalent epidemiological characteristics of our patients with blepharitis, the main etiological agents, clinical presentations, the best treatment, and the progression of the disease. […] Evaluation of our patients’ follow-up showed that 82.4% of patients did not return to evaluate the treatment outcome, with only 17.6% returning.
  • #73
    https://journals.lww.com/pajo/fulltext/2023/08310/prevalence_of_blepharitis_in_adult_patients_in.30.aspx
    In this study, the prevalence of blepharitis in adult patients that consulted with eye care specialists at the Fundacin Oftalmolgica Nacional between July and October 2021 was 68%. The most frequent type was posterior blepharitis in 55.8% of patients, followed by marginal blepharitis in 31.6%, and anterior blepharitis in 12.6%. […] The considerable overlapping of symptoms and signs with other pathologies, such as dry eye or allergic conjunctivitis, leads to confusion when establishing a primary diagnosis. This overlapping of symptoms ultimately masks blepharitis as the underlying pathology leaving it untreated, while treatment focuses solely on allergic and dry eye symptoms. […] There is a clear need for prevalence studies of anterior, marginal, and posterior blepharitis in the region to help us define frequency and association with local risk factors as well as more data to create prevention strategies. […] However, the prevalence and the characteristics of the pathology found suggest blepharitis is being overlooked and underdiagnosed, and therefore, left untreated, affecting the quality of life of many patients.